Michael Goldberg is the founder of SURGE Therapeutics. SURGE Therapeutics has raised $58M, latest Series B $32M (2023). Biotech · Cambridge, MA.
Michael Goldberg is the founder of SURGE Therapeutics. SURGE Therapeutics operates in Biotech and is based in Cambridge, MA. SURGE Therapeutics has raised $58M, latest Series B $32M (2023). Backers on record include Angela Ni, Bioluminescence Ventures.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Cambridge — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library